In addition to genetic loss of TSC1 or TSC2, mTORC1 activity can also be stimulated by the activation of PI3K/AKT signaling pathway, such as the inactivation of the tumor suppressor PTEN or the overexpression of the constitutively activated AKT 13. This evidence concerns the gene TSC1 and neoplasm.